sur ORPHAN SYNERGY EUROPE-PHARMA (EPA:OSE)
OSE Immunotherapeutics unveils its financial calendar for 2026
OSE Immunotherapeutics, located in Nantes, has announced its financial calendar for 2026. The company will publish its 2025 annual financial results on April 29, 2026, followed by its first-quarter cash position on April 30, 2026. The Annual General Meeting of Shareholders is scheduled for June 24, 2026. First-half 2026 financial results will be announced on September 28, and the third-quarter cash position will be published on October 27. Finally, the fourth-quarter cash position will be released on January 26, 2027.
This schedule is indicative and subject to change. For up-to-date information, please consult the company's official website.
R. P.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de ORPHAN SYNERGY EUROPE-PHARMA